Integrative metagenomic analysis reveals distinct gut microbial signatures related to obesity.

Obesity is a metabolic disorder closely associated with profound alterations in gut microbial composition. However, the dynamics of species composition and functional changes in the gut microbiome in obesity remain to be comprehensively investigated. In this study, we conducted a meta-analysis of metagenomic sequencing data from both obese and non-obese individuals across multiple cohorts, totaling 1351 fecal metagenomes. Our results demonstrate a significant decrease in both the richness and diversity of the gut bacteriome and virome in obese patients. We identified 38 bacterial species including Eubacterium sp. CAG:274, Ruminococcus gnavus, Eubacterium eligens and Akkermansia muciniphila, and 1 archaeal species, Methanobrevibacter smithii, that were significantly altered in obesity. Additionally, we observed altered abundance of five viral families: Mesyanzhinovviridae, Chaseviridae, Salasmaviridae, Drexlerviridae, and Casjensviridae. Functional analysis of the gut microbiome indicated distinct signatures associated to obesity and identified Ruminococcus gnavus as the primary driver for function enrichment in obesity, and Methanobrevibacter smithii, Akkermansia muciniphila, Ruminococcus bicirculans, and Eubacterium siraeum as functional drivers in the healthy control group. Additionally, our results suggest that antibiotic resistance genes and bacterial virulence factors may influence the development of obesity. Finally, we demonstrated that gut vOTUs achieved a diagnostic accuracy with an optimal area under the curve of 0.766 for distinguishing obesity from healthy controls. Our findings offer comprehensive and generalizable insights into the gut bacteriome and virome features associated with obesity, with the potential to guide the development of microbiome-based diagnostics.

Microbial collaborations and conflicts: unraveling interactions in the gut ecosystem.

The human gut microbiota constitutes a vast and complex community of microorganisms. The myriad of microorganisms present in the intestinal tract exhibits highly intricate interactions, which play a crucial role in maintaining the stability and balance of the gut microbial ecosystem. These interactions, in turn, influence the overall health of the host. The mammalian gut microbes have evolved a wide range of mechanisms to suppress or even eliminate their competitors for nutrients and space. Simultaneously, extensive cooperative interactions exist among different microbes to optimize resource utilization and enhance their own fitness. This review will focus on the competitive mechanisms among members of the gut microorganisms and discuss key modes of actions, including bacterial secretion systems, bacteriocins, membrane vesicles (MVs) etc. Additionally, we will summarize the current knowledge of the often-overlooked positive interactions within the gut microbiota, and showcase representative machineries. This information will serve as a reference for better understanding the complex interactions occurring within the mammalian gut environment. Understanding the interaction dynamics of competition and cooperation within the gut microbiota is crucial to unraveling the ecology of the mammalian gut microbial communities. Targeted interventions aimed at modulating these interactions may offer potential therapeutic strategies for disease conditions.

Poly[bis-[µ-1,4-bis-(imidazol-1-ylmeth-yl)benzene]dichloridocadmium(II)].

The title compound, [CdCl(2)(C(14)H(14)N(4))(2)](n), has a slightly distorted octa-hedral coordination geometry, formed by four N atoms from 1,4-bis-(imidazol-1-ylmeth-yl)benzene ligands and two Cl atoms, giving a two-dimensional network. The Cd atom lies on a centre of inversion.

Bis{µ-2,2'-[o-phenyl-enebis(nitrilo-methyl-idyne)]diphenolato}dicopper(II) N,N'-dimethyl-formamide disolvate.

The title compound, [Cu(2)(C(20)H(14)N(2)O(2))(2)]·2C(3)H(7)NO, consists of a centrosymmetric dimer composed of two copper(II) ions and two tetra-dentate salphen ligands {H(2)salphen is 2,2'-[o-phenyl-enebis(nitrilo-methyl-idyne)]diphenol}, and two dimethyl-formamide solvent mol-ecules. The Cu(II) atom is bonded to two N imino atoms and three phenolate O atoms of salphen. One deprotonated phenol group of each ligand bridges two Cu atoms, forming the dimer. The geometry about the five-coordinate Cu atom can best be described as slightly distorted recta-ngular pyramidal. The crystal structure is stabilized by π-π inter-actions [centroid-centroid distance 3.779 (2) Å] and C-H⋯O hydrogen bonds.

Recent Development of Coumarin Derivatives as Potential Antiplasmodial and Antimalarial Agents.

Malaria still remains one of the leading deadliest diseases throughout the world, leading to around 1 million deaths annually. The emergence and spread of growing resistance to the firstline antimalarials are an alarming the serious problem in malaria control, demanding the need for new drugs more potent than earlier with improved Absorption, Distribution, Metabolism, and Excretion (ADME) profiles. Coumarins, which exhibited various biological properties, also displayed potential in vitro antiplasmodial and in vivo antimalarial activities. Moreover, many of coumarin derivatives have already been used in clinical practice for the treatment of several diseases. Therefore, coumarin derivatives play a pivotal role in medicinal chemistry, also making them promising candidates for the treatment of malaria. This review aims to summarize the recent advances made towards the development of coumarin-containing derivatives as antiplasmodial and antimalarial agents and their structure-activity relationship is also discussed.

Constructing Unique Cathode Interface by Manipulating Functional Groups of Electrolyte Additive for Graphite/LiNi0.6Co0.2Mn0.2O2 Cells at High Voltage.

A novel electrolyte additive, 1-(2-cyanoethyl) pyrrole (CEP), has been investigated to improve the electrochemical performance of graphite/LiNi0.6Co0.2Mn0.2O2 cells cycling up to 4.5 V vs Li/Li+. The 4.5 V cycling results present that after 50 cycles, up to 4.5 V capacity retention of the graphite/LiNi0.6Co0.2Mn0.2O2 cell is improved significantly from 27.4 to 81.5% when adding 1% CEP to baseline electrolyte (1 M LiPF6 in EC/EMC 1:2, by weight). Ex situ characterization results support the mechanism of CEP for enhancing the electrochemical performance. On one hand, the significant enhancement is ascribed to a formed superior cathode interfacial film by preferential oxidation of CEP on the cathode electrode surface suppressing electrolyte decomposition at high voltage. On the other hand, the duo Lewis base functional groups can effectively capture dissociation product PF5 from LiPF6 with the presence of an unavoidable trace amount of water or aprotic impurities in the electrolyte. Thus this mitigates the hydrofluoric acid (HF) generation that leads to the reduction of transition-metal dissolution in the electrolyte upon cycling at high voltage. The theoretical modeling suggests that CEP has a mechanism of stabilizing electrolyte via combination of -C≡N: functional group and H2O. The work presented here also shows nuclear magnetic resonance spectra analysis to prove the capability of CEP reducing HF generation and X-ray photoelectron spectroscopy analysis to observe cathode surface composition.

Recent Developments of Coumarin Hybrids as Anti-fungal Agents.

Fungi place a huge burden on global healthcare systems attributed to the fact that fungal infections are responsible for the high morbidity and mortality rates in patients who received stem cell transplantation, antineoplastic chemotherapy, organ transplants or suffered Human Immunodeficiency Virus (HIV) infection. Unfortunately, almost none of the representative anti-fungal agents currently used in clinical therapy are ideal in terms of efficacy, anti-fungal spectrum or safety. Moreover, the rapid development of resistance to existing anti-fungal drugs has further aggravated the mortality and spread of fungi, creating an urgent need for novel anti-fungal agents. The broad spectrum of biological activities and successful usage in clinic made coumarins a promising anti-fungal candidate. Furthermore, hybridization of other pharmacophores with coumarin motif may enhance the anti-fungal efficacy, broaden the anti-fungal spectrum and improve the safety profiles. Thus, numerous coumarin hybrids have been assessed for their anti-fungal activities, and some of them showed promising potency and may have a novel mechanism of action. This review aims to outline the recent development of coumarin hybrids as potential anti-fungal agents and summarize their Structure-Activity Relationship (SAR) to provide an insight for rational designs of more active agents.

Antibacterial evaluation of novel organoarsenic compounds by the microcalorimetric method.

Antibacterial activities of novel organoarsenic compounds As(III)-containing Schiff bases on Escherichia coli (CCTCCAB91112) were investigated by microcalorimetry in this study. The experimental result showed that the arsenic(III)-containing Schiff bases at micromolar concentration exhibit strong inhibition on the E. coli. Specifically, the growth rate constant k decreased, and the generation time t G and the inhibitory ratio I (percentage) increased with the increased dose of the arsenicals as inhibitors. All of the arsenicals display the feature of considerable lag phase inhibition on the cell growth. The compound 4-(4-bromobenzaliminyl)phenylarsenoxide makes the lag phase of E. coli cell growth cycles to reach 650 min at 5 µmol/L. The compounds with donating electron groups at aromatic ring B have lower IC50 to present higher antibacterial activity. The compound 4-(4-hydroxyl-3-methoxylbenzaliminyl)phenylarsenoxide has the lowest IC50 (1.82 µmol/L) to show the strongest antibacterial activity among them.